• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Recombinant Proteins / Fusion Proteins
You are here: Product Lines > Proteins > Recombinant Proteins / Fusion Proteins
Toolbar - View Selection
 
 Items 180-200 of 508 Page 10 of 26 Select Page: << 6 7 8 9 10 11 12 13 14 15  >>  
ALX-201-153 Revised 10-Feb-05
DsbA (E. coli) (recombinant)
Add to Clipboard
SYNONYMS Thiol:disulfide Interchange Protein DsbA (E. coli) (recombinant)
PRODUCT LINE Stress & Heat Shock Proteins
PRODUCT CATEGORY Heat Shock Proteins Other Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-153-C025   25 µg 35.00 USD Add To Cart
Product Specification
SOURCE/HOST: Produced in E. coli.
CONCENTRATION: 1mg/ml
PURITY: ≥99%
FORMULATION: Liquid. In water.
SHIPPING: SHIPPED ON DRY ICE
SHORT TERM STORAGE: +4°C
LONG TERM STORAGE: -80°C
HANDLING: Avoid freeze/thaw cycles. For maximum product recovery after thawing, centrifuge the vial before opening the cap.
Product Specific Literature References
DsbA and DsbC-catalyzed oxidative folding of proteins with complex disulfide bridge patterns in vitro and in vivo: K. Maskos, et al.; J. Mol. Biol. 325, 495 (2003) Abstract
General Information
BACKGROUND/TECHNICAL INFORMATION Swiss-Prot link P59589: Thiol:disulfide Interchange Protein DsbA (Precursor) (E. coli)
General Literature References
Oxidative protein folding in bacteria: J.F. Collet & J.C. Bardwell; Mol. Microbiol. 44, 1 (2002) Abstract
Further Categories Containing This Product:
Recombinant Proteins / Fusion Proteins
 
 
ALX-201-268 Revised 18-Mar-08
DsbC (E. coli) (recombinant)
Add to Clipboard
SYNONYMS Thiol:disulfide Interchange Protein DsbC (E. coli) (recombinant)
PRODUCT LINE Stress & Heat Shock Proteins
PRODUCT CATEGORY Heat Shock Proteins Other Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-268-C100   100 µg 220.00 USD Add To Cart
Product Specification
MW: ~23.5kDa
SOURCE/HOST: Produced in E. coli.
CONCENTRATION: 1mg/ml
PURITY: ≥95% (SDS-PAGE)
FORMULATION: Liquid. In 20mM TRIS, pH 7.5, containing 2mM EDTA.
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: -20°C
HANDLING: Avoid freeze/thaw cycles.
Product Images
Please click on thumbnails to enlarge.
Product Specific Literature References
DsbA and DsbC-catalyzed oxidative folding of proteins with complex disulfide bridge patterns in vitro and in vivo: K. Maskos, et al.; J. Mol. Biol. 325, 495 (2003) Abstract
General Information
BACKGROUND/TECHNICAL INFORMATION Swiss-Prot link P0AEG6: Thiol:disulfide Interchange Protein DsbC (Precursor) (E. coli)
Further Categories Containing This Product:
Recombinant Proteins / Fusion Proteins
 
 
ALX-522-038 Revised 27-Mar-08
EDA-A1, Soluble (human) (recombinant)
Add to Clipboard
SYNONYMS Ectodysplasin-A1, Soluble (human) (recombinant)
PRODUCT LINE Chemokines & Cytokines
PRODUCT CATEGORY EDA & EDAR, Troy / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-522-038-C010   10 µg 360.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
MW: ~20kDa (SDS-PAGE).
SOURCE/HOST: Produced in E. coli. The extracellular domain of human EDA-A1 (ectodysplasin-A1) (aa 245-391) is fused at the N-terminus to a linker peptide (9 aa) and a FLAG®-tag.
CONCENTRATION: 0.1mg/ml after reconstitution.
PURITY: ≥95% (SDS-PAGE)
FORMULATION: Lyophilized. Contains PBS.
ENDOTOXIN CONTENT: <0.1EU/µg purified protein (LAL test; Bio Whittaker).
RECONSTITUTION: Reconstitute with 100µl sterile water. Further dilutions should be made with medium containing 5% fetal calf serum.
SPECIFICITY: Binds to human EDAR (ectodysplasin-A1 receptor).
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: -20°C
USE/STABILITY: Stable for at least 6 months after receipt when stored at -20°C.
Product Specific Literature References
Mutations leading to X-linked hypohidrotic ectodermal dysplasia affect three major functional domains in the tumor necrosis factor family member ectodysplasin-A: P. Schneider, et al.; J. Biol. Chem. 276, 18819 (2001) Abstract; Full Text
General Information
BACKGROUND/TECHNICAL INFORMATION Swiss-Prot link Q92838: EDA-A1 (human)

FLAG is a registered trademark of Sigma-Aldrich Co.
MANUFACTURER Manufactured by Apotech Corporation.
Further Categories Containing This Product:
TNF-alpha & TNF Receptors Other Products • Recombinant Proteins / Fusion Proteins
 
 
ALX-522-048 Revised 24-Oct-06
EDA-A2, Soluble (human) (recombinant)
Add to Clipboard
SYNONYMS Ectodysplasin-A2, Soluble (human) (recombinant)
PRODUCT LINE Chemokines & Cytokines
PRODUCT CATEGORY EDA & EDAR, Troy / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-522-048-C010   10 µg 360.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
MW: ~28kDa (SDS-PAGE).
SOURCE/HOST: Produced in HEK 293 cells. The extracellular domain of human EDA-A2 (ectodysplasin-A2) (aa 245-391) is fused at the N-terminus to a linker peptide (10 aa) and a FLAG®-tag.
CONCENTRATION: 0.1mg/ml after reconstitution.
PURITY: ≥90% (SDS-PAGE)
FORMULATION: Lyophilized. Contains PBS.
ENDOTOXIN CONTENT: <0.1EU/µg purified protein (LAL test; Bio Whittaker).
RECONSTITUTION: Reconstitute with 100µl sterile water. Further dilutions should be made with medium containing 5% fetal calf serum.
SPECIFICITY: Binds to human XEDAR (X-linked ectodysplasin-A2 receptor).
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: -20°C
USE/STABILITY: Stable for at least 6 months after receipt when stored at -20°C.
Product Specific Literature References
Mutations leading to X-linked hypohidrotic ectodermal dysplasia affect three major functional domains in the tumor necrosis factor family member ectodysplasin-A: P. Schneider, et al.; J. Biol. Chem. 276, 18819 (2001) Abstract; Full Text
General Information
BACKGROUND/TECHNICAL INFORMATION FLAG is a registered trademark of Sigma-Aldrich Co.
MANUFACTURER Manufactured by Apotech Corporation.
Further Categories Containing This Product:
TNF-alpha & TNF Receptors Other Products • Recombinant Proteins / Fusion Proteins
 
 
ALX-522-037 Revised 24-Oct-06
EDAR (human):Fc (human) (recombinant)
Add to Clipboard
SYNONYMS Anhidrotic Ectodysplasin-A1 Receptor (human):Fc (human) (recombinant)
EDA-A1 Receptor (human):Fc (human) (recombinant)
TNFRSF EDAR (human):Fc (human) (recombinant)
PRODUCT LINE Chemokines & Cytokines
PRODUCT CATEGORY EDA & EDAR, Troy / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-522-037-C050   50 µg 360.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
SOURCE/HOST: Produced in E. coli. The cysteine-rich region of human EDAR (ectodysplasin-A receptor) (aa 1-183) is fused to the Fc portion of human IgG1.
CONCENTRATION: 1mg/ml after reconstitution.
PURITY: ≥95% (SDS-PAGE)
FORMULATION: Lyophilized. Contains PBS.
ENDOTOXIN CONTENT: <0.1EU/µg purified protein (LAL test; Bio Whittaker).
RECONSTITUTION: Reconstitute with 50µl sterile water. Further dilutions should be made with medium containing 5% fetal calf serum.
SPECIFICITY: Binds human EDA-A1 (ectodysplasin-A1).
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: -20°C
USE/STABILITY: Stable for at least 6 months after receipt when stored at -20°C.
Product Specific Literature References
Mutations leading to X-linked hypohidrotic ectodermal dysplasia affect three major functional domains in the tumor necrosis factor family member ectodysplasin-A: P. Schneider, et al.; J. Biol. Chem. 276, 18819 (2001) Abstract; Full Text
General Information
BACKGROUND/TECHNICAL INFORMATION Swiss-Prot link Q9UNE0: EDAR (human) (precursor)
MANUFACTURER Manufactured by Apotech Corporation.
Related Products
Further Categories Containing This Product:
Recombinant Proteins / Fusion Proteins
 
 
ALX-201-074 Revised 18-Sep-07
EGR-1 Protein (human) (recombinant)
Add to Clipboard
SYNONYMS Early Growth Response Protein 1 (human) (recombinant)
NGFI-A (human) (recombinant)
krox24 (human) (recombinant)
TIS-8 (human) (recombinant)
zif 268 (human) (recombinant)
pat 225 (human) (recombinant)
PRODUCT LINE DNA Regulation / Transcription
PRODUCT CATEGORY Egr Protein Family / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-074-1   1 Vial 365.00 USD Add To Cart
Product Specification
SOURCE/HOST: Produced in Sf9 cells.
QUANTITY: 50µl, corresponding to >25 band forming units (BFU). Sufficient for performing at least 25 gel shift assays under standard conditions [2].
FORMULATION: Liquid. In 20mM HEPES, pH 7.9, containing 25% glycerol, 420mM sodium chloride, 0.2mM EDTA and 1.5mM magnesium chloride.
SPECIFICITY: Binds specifically to an oligonucleotide with the sequence GCG GGG GCG.
SPECIFIC ACTIVITY: >0.5BFU/µl. 1BFU is sufficient to generate a band shift with a labelled oligonucleotide.
APPLICATION: EMSA promoter characterization, in vitro transcription assays, analysis of nuclear extracts (oligonucleotides and recombinant protein serve as a positive control).
SHIPPING: SHIPPED ON DRY ICE
LONG TERM STORAGE: -80°C
HANDLING: Avoid freeze/thaw cycles.
Product Description
The recombinant EGR-1 protein can be employed in the following fields of research: a) Promoter studies: Identification of EGR-1 binding promoter elements. b) Detection of EGR-1 interacting proteins. c) Signal transduction: Assay for the effect on the nuclear component EGR-1. d) Screening for EGR-1 activity in tumor cells and lines. e) Drug screening: Effect on EGR-1 generation and DNA binding.
Product Specific Literature References
A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1: C. Skerka, et al.; J. Biol. Chem. 270, 22500 (1995) Abstract; Full Text
The early growth response protein (EGR-1) regulates interleukin-2 transcription by synergistic interaction with the nuclear factor of activated T cells: E.L. Decker, et al.; J. Biol. Chem. 273, 26923 (1998) Abstract; Full Text
The human zinc finger protein EGR-4 acts as autoregulatory transcriptional repressor: P.F. Zipfel, et al.; Biochim. Biophys. Acta. 1354, 134 (1997) Abstract
Zinc finger transcription factors as molecular targets for nitric oxide-mediated immunosuppression: inhibition of IL-2 gene expression in murine lymphocytes: D. Berendji, et al.; Mol. Med. 5, 721 (1999) Abstract
Fibroblast growth factor-2 induction of platelet-derived growth factor-C chain transcription in vascular smooth muscle cells is ERK-dependent but not JNK-dependent and mediated by Egr-1: V.C. Midgley and L.M. Khachigian; J. Biol. Chem. 279, 40289 (2004) Abstract; Full Text
General Information
Early Growth Response- (EGR-) proteins represent a family of related transcription factors with almost identical DNA- binding zinc finger domains, but with different flanking regions. All four human EGR-proteins, EGR-1 to EGR-4 bind the EGR-consensus sequence GCG T/GGG GCG. However individual EGR-proteins show different binding to related sequences, such as the overlapping EGR-1/Sp1 binding site in the human IL-2 gene promoter. In functional assays the EGR-4 protein shows superior performance for Electrophoretic Mobility Shift Assay (EMSA) compared to proteins expressed in E.coli.
BACKGROUND/TECHNICAL INFORMATION For EMSA labeled oligonucleotides are required, that include the specific target sequence. Radioactive labeling of the oligonucleotide is performed by kinase reaction (T4 kinase) using either 32P-γ ATP or 33P-γ ATP as a source for radioactivity. Due to the lower radiation load we recommend the use of 33P-γ ATP, which results in specific, detectable bands. Formation of a specific protein: DNA complex results in a lower mobility of this complex compared to the mobility of the free DNA. The specificity of the EMSA can also be analyzed by competition experiments in which an excess of unlabeled specific oligonucleotide interferes with the formation of a specific band, while the same amount of unrelated or mutated oligonucleotide has no effect. DNA-Protein complexes are then separated from the free (unbound) oligonucleotides by native gel-electrophoresis.

Swiss-Prot link P18146: EGR-1 (human)
AfCS Signalling Gateway link A003269: EGR-1 (mouse)
General Literature References
A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization: V.P. Sukhatme, et al.; Cell 53, 37 (1988) Abstract
Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals: X.M. Cao, et al.; Mol. Cell. Biol. 10, 1931 (1990) Abstract
Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factor: A. Gashler & V.P. Sukhatme; Prog. Nucleic Acid Res. Mol. Biol. 50, 191 (1995) Abstract
Further Categories Containing This Product:
Recombinant Proteins / Fusion Proteins
 
 
ALX-201-223 Revised 04-Aug-05
EGR-2 Protein (human) (recombinant)
Add to Clipboard
SYNONYMS Early Growth Response Protein 2 (human) (recombinant)
Krox-20 Protein (human) (recombinant)
pAT591 (human) (recombinant)
PRODUCT LINE DNA Regulation / Transcription
PRODUCT CATEGORY Egr Protein Family / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-223-1   1 Vial 390.00 USD Add To Cart
Product Specification
SOURCE/HOST: Produced in Sf9 cells.
QUANTITY: 150µl. Sufficient for >10 Western blots or >70 gel shift assays under standard conditions.
FORMULATION: Liquid. In 20mM HEPES, pH 7.9, containing 25% glycerol, 420mM sodium chloride, 0.2mM EDTA and 1.5mM magnesium chloride.
BIOLOGICAL ACTIVITY: Interacts with NFκB protein p65.
APPLICATION: EMSA promoter characterization, in vitro transcription assay, analysis of nuclear extracts (oligonucleotides and recombinant protein serve as positive control).
SHIPPING: SHIPPED ON DRY ICE
LONG TERM STORAGE: -80°C
HANDLING: Avoid freeze/thaw cycles.
Product Description
The recombinant EGR-2 protein can be employed in the following fields of research: a) Promoter studies: Identification of EGR-2 binding promoter elements. b) Detection of EGR-2 interacting proteins. c) Signal transduction: Assay for the effect on the nuclear component EGR-2. d) Screening for EGR-2 activity in tumor cells and lines. e) Drug screening: Effect on EGR-2 generation and DNA binding.
Product Specific Literature References
Coordinate expression and distinct DNA-binding characteristics of the four EGR-zinc finger proteins in Jurkat T lymphocytes: C. Skerka, et al.; Immunobiology 198, 179 (1997) Abstract
Egr-2 and Egr-3 are negative regulators of T cell activation: M. Safford, et al.; Nat. Immunol. 6, 472 (2005) Abstract
General Information
BACKGROUND/TECHNICAL INFORMATION For EMSA labeled oligonucleotides are required, that include the specific target sequence. Radioactive labeling of the oligonucleotide is performed by kinase reaction (T4 kinase) using either 32P-ATP or 33P-ATP as a source for radioactivity. Due to the lower radiation load we recommend the use of 33P-ATP, which results in specific, detectable bands. Formation of a specific protein: DNA complex results in a lower mobility of this complex compared to the mobility of the free DNA. The specificity of the EMSA can also be analyzed by competition experiments in which an excess of unlabeled specific oligonucleotide interferes with the formation of a specific band, while the same amount of unrelated or mutated oligonucleotide has no effect. DNA-Protein complexes are then separated from the free (unbound) oligonucleotides by native gel-electrophoresis.
Swiss-Prot link P11161: EGR-2 (human)
Further Categories Containing This Product:
Recombinant Proteins / Fusion Proteins
 
 
ALX-201-075 Revised 02-May-06
EGR-3 Protein (human) (recombinant)
Add to Clipboard
SYNONYMS Early Growth Response Protein 3 (human) (recombinant)
Pilot (human) (recombinant)
PRODUCT LINE DNA Regulation / Transcription
PRODUCT CATEGORY Egr Protein Family / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-075-1   1 Vial 395.00 USD Add To Cart
Product Specification
SOURCE/HOST: Produced in Sf9 cells.
QUANTITY: 75µl, corresponding to >25 band forming units (BFU). Sufficient for performing at least 25 gel shift assays under standard conditions.
FORMULATION: Liquid. In 20mM HEPES, pH 7.9, containing 25% glycerol, 420mM sodium chloride, 0.2mM EDTA and 1.5mM magnesium chloride.
SPECIFICITY: Binds specifically to an oligonucleotide with the sequence GCG GGG GCG.
SPECIFIC ACTIVITY: >0.33BFU/µl. 1BFU is sufficient to generate a band shift with a labelled oligonucleotide.
APPLICATION: EMSA promoter characterization, in vitro transcription assay, analysis of nuclear extracts (oligonucleotides and recombinant protein serve as positive control).
SHIPPING: SHIPPED ON DRY ICE
LONG TERM STORAGE: -80°C
HANDLING: Avoid freeze/thaw cycles.
Product Description
The recombinant EGR-3 protein can be employed in the following fields of research: a) Promoter studies: Identification of EGR-3 binding promoter elements. b) Detection of EGR-3 interacting proteins. c) Signal transduction: Assay for the effect on the nuclear component EGR-3. d) Screening for EGR-3 activity in tumor cells and lines. e) Drug screening: Effect on EGR-3 generation and DNA binding.
Product Specific Literature References
EGR3, a novel member of the Egr family of genes encoding immediate- early transcription factors: S. Patwardhan, et al.; Oncogene 6, 917 (1991) Abstract
Coordinate expression and distinct DNA-binding characteristics of the four EGR-zinc finger proteins in Jurkat T lymphocytes: C. Skerka, et al.; Immunobiology 198, 179 (1997) Abstract
The human zinc finger protein EGR-4 acts as autoregulatory transcriptional repressor: P.F. Zipfel, et al.; Biochim. Biophys. Acta 354, 134 (1997) Abstract
The early growth response protein (EGR-1) regulates interleukin-2 transcription by synergistic interaction with the nuclear factor of activated T cells: E.L. Decker, et al.; J. Biol. Chem. 273, 26923 (1998) Abstract; Full Text
Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression: P.R. Mittelstadt & J.D. Ashwell; Mol. Cell. Biol. 18, 3744 (1998) Abstract; Full Text
Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells: P.R. Mittelstadt & J.D. Ashwell; J. Biol. Chem. 274, 3222 (1999) Abstract; Full Text
General Information
Early Growth Response- (EGR-) proteins represent a family of related transcription factors with almost identical DNA- binding zinc finger domains, but with different flanking regions. All four human EGR-proteins, EGR-1 to EGR-4 bind the EGR-consensus sequence GCG T/GGG GCG. However individual EGR-proteins show different binding to related sequences, such as the overlapping EGR-1/Sp1 binding site in the human IL-2 gene promoter. In functional assays the EGR-4 protein shows superior performance for Electrophoretic Mobility Shift Assay (EMSA) compared to proteins expressed in E.coli.
BACKGROUND/TECHNICAL INFORMATION For EMSA labeled oligonucleotides are required, that include the specific target sequence. Radioactive labeling of the oligonucleotide is performed by kinase reaction (T4 kinase) using either 32P-γ ATP or 33P-γ ATP as a source for radioactivity. Due to the lower radiation load we recommend the use of 33P-γ ATP, which results in specific, detectable bands. Formation of a specific protein: DNA complex results in a lower mobility of this complex compared to the mobility of the free DNA. The specificity of the EMSA can also be analyzed by competition experiments in which an excess of unlabeled specific oligonucleotide interferes with the formation of a specific band, while the same amount of unrelated or mutated oligonucleotide has no effect. DNA-Protein complexes are then separated from the free (unbound) oligonucleotides by native gel-electrophoresis.

Swiss-Prot link Q06889: EGR-3 (human)
Further Categories Containing This Product:
Recombinant Proteins / Fusion Proteins
 
 
ALX-201-076 Revised 26-Jul-05
EGR-4 Protein (human) (recombinant)
Add to Clipboard
SYNONYMS Early Growth Response Protein 4 (human) (recombinant)
PRODUCT LINE DNA Regulation / Transcription
PRODUCT CATEGORY Egr Protein Family / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-076-1   1 Vial 395.00 USD Add To Cart
Product Specification
SOURCE/HOST: Produced in Sf9 cells.
QUANTITY: 10µl. Sufficient for >10 Western blots or >50 gel shift assays under standard conditions.
FORMULATION: Liquid. In 20mM HEPES, pH 7.9, containing 25% glycerol, 420mM sodium chloride, 0.2mM EDTA and 1.5mM magnesium chloride.
BIOLOGICAL ACTIVITY: Binds specifically to an oligonucleotide with the sequence GCG GGG GCG.
APPLICATION: EMSA promoter characterization, in vitro transcription assay, analysis of nuclear extracts (oligonucleotides and recombinant protein serve as positive control).
SHIPPING: SHIPPED ON DRY ICE
LONG TERM STORAGE: -80°C
HANDLING: Avoid freeze/thaw cycles.
Product Description
The recombinant EGR-4 protein can be employed in the following fields of research: a) Promoter studies: Identification of EGR-4 binding promoter elements. b) Detection of EGR-4 interacting proteins. c) Signal transduction: Assay for the effect on the nuclear component EGR-4. d) Screening for EGR-4 activity in tumor cells and lines. e) Drug screening: Effect on EGR-4 generation and DNA binding.
Product Specific Literature References
The human zinc finger protein EGR-4 acts as autoregulatory transcriptional repressor: P.F. Zipfel, et al.; Biochim. Biophys. Acta 1354, 134 (1997) Abstract
The early growth response protein (EGR-1) regulates interleukin-2 transcription by synergistic interaction with the nuclear factor of activated T cells: E.L. Decker, et al.; J. Biol. Chem. 273, 26923 (1998) Abstract; Full Text
General Information
Early Growth Response- (EGR-) proteins represent a family of related transcription factors with almost identical DNA- binding zinc finger domains, but with different flanking regions. All four human EGR-proteins, EGR-1 to EGR-4 bind the EGR-consensus sequence GCG T/GGG GCG. However individual EGR-proteins show different binding to related sequences, such as the overlapping EGR-1/Sp1 binding site in the human IL-2 gene promoter. In functional assays the EGR-4 protein shows superior performance for Electrophoretic Mobility Shift Assay (EMSA) compared to proteins expressed in E.coli.
BACKGROUND/TECHNICAL INFORMATION

For EMSA labeled oligonucleotides are required, that include the specific target sequence. Radioactive labeling of the oligonucleotide is performed by kinase reaction (T4 kinase) using either 32P-ATP or 33P-ATP as a source for radioactivity. Due to the lower radiation load we recommend the use of 33P-ATP, which results in specific, detectable bands. Formation of a specific protein: DNA complex results in a lower mobility of this complex compared to the mobility of the free DNA. The specificity of the EMSA can also be analyzed by competition experiments in which an excess of unlabeled specific oligonucleotide interferes with the formation of a specific band, while the same amount of unrelated or mutated oligonucleotide has no effect. DNA-Protein complexes are then separated from the free (unbound) oligonucleotides by native gel-electrophoresis.
Swiss-Prot link Q05215: EGR-4 (human)
General Literature References
The early response gene NGFI-C encodes a zinc finger transcriptional activator and is a member of the GCGGGGGCG (GSG) element-binding protein family: S.D. Crosby, et al.; Mol. Cell. Biol. 11, 3835 (1991) Abstract
Clone pAT 133 identifies a gene that encodes another human member of a class of growth factor-induced genes with almost identical zinc-finger domains: H.J. Muller, et al.; PNAS 88, 10079 (1991) Abstract
Genomic organization, chromosomal localization and promoter function of the human zinc-finger gene pAT133: C. Holst, et al.; Hum. Mol. Genet. 2, 367 (1993) Abstract
Neural-specific expression, genomic structure, and chromosomal localization of the gene encoding the zinc-finger transcription factor NGFI-C: S.D. Crosby, et al.; PNAS 89, 4739 (1992) Abstract
Further Categories Containing This Product:
Recombinant Proteins / Fusion Proteins